<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ascending thoracic <z:hpo ids='HP_0004942'>aortic aneurysms</z:hpo> leading to type A dissections (TAAD) can occur in association with a <z:e sem="disease" ids="C0567439" disease_type="Disease or Syndrome" abbrv="">genetic syndrome</z:e>, such as <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>), or as an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disorder in the absence of syndromic features, termed familial TAAD </plain></SENT>
<SENT sid="1" pm="."><plain>Familial TAAD demonstrates <z:hpo ids='HP_0001425'>genetic heterogeneity</z:hpo>, and linkage studies have identified three TAAD loci at 5q13-14 (TAAD1), 11q23 (FAA1), and 3p24-25 (TAAD2) </plain></SENT>
<SENT sid="2" pm="."><plain>The underlying <z:hpo ids='HP_0001425'>genetic heterogeneity</z:hpo> of TAAD is reflected in the phenotypic variation associated with familial TAAD with respect to <z:hpo ids='HP_0011007'>age of onset</z:hpo>, progression, penetrance, and association with additional cardiac and vascular features </plain></SENT>
<SENT sid="3" pm="."><plain>Recently, mutations in the TGFBR2 gene have been identified as the cause of disease linked to the TAAD2 locus, supporting the hypothesis that dysregulation of TGFbeta signaling is a mechanism leading to <z:hpo ids='HP_0002617'>aneurysms</z:hpo> and dissections </plain></SENT>
<SENT sid="4" pm="."><plain>The recent identification of the TGFbeta pathway as a key target in the molecular pathogenesis of TAAD has opened new avenues for future genetic and therapeutic research </plain></SENT>
</text></document>